NCT00646594View on ClinicalTrials.gov

Atlantis Symbicort

PHASE3CompletedINTERVENTIONAL

Enrollment

1,200

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

January 31, 2005

Conditions

Asthma

Interventions

DRUG

budesonide/formoterol (Symbicort)

DRUG

fluticasone/salmeterol (Advair)

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY